INVENTIVA SA IVA
ADS · ADR · CUSIP 46124U107
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $5.68.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2020 | 18 |
| Q4 2020 | 16 |
| Q1 2021 | 14 |
| Q2 2021 | 15 |
| Q3 2021 | 13 |
| Q4 2021 | 11 |
| Q1 2022 | 11 |
| Q2 2022 | 11 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2020 | 3 | 11 |
| Q1 2021 | 7 | 9 |
| Q2 2021 | 7 | 5 |
| Q3 2021 | 5 | 6 |
| Q4 2021 | 1 | 5 |
| Q1 2022 | 5 | 0 |
| Q2 2022 | 5 | 2 |
Biggest buyers
| NEA Management Company, LLC | Added | +4.3m |
| Yiheng Capital Management, L.P. | Added | +982.7k |
| CREDIT SUISSE AG/ | New | +3.5k |
| UBS Group AG | Added | +1.0k |
| MORGAN STANLEY | Added | +800 |
Biggest sellers
| Commodore Capital LP | Reduced | -87.2k |
| Fortitude Advisory Group L.L.C. | Sold out | -133 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Invus Global Management, LLC 13G · passive investor +2.8 pts · filed 2025-07-31 | 10.6% |
| Sofinnova Crossover I 13G · exempt (held before listing) +1.4 pts · filed 2026-02-17 | 8.6% |
| Samsara BioCapital, L.P. 13D · may seek influence +1.5 pts · filed 2025-11-19 | 7.4% |
| Andera Partners 13G · passive investor -1.0 pts · filed 2026-10-27 | 6.7% |
| Yiheng Capital Management, L.P. 13G · institution -2.9 pts · filed 2025-11-13 | 5.5% |
Fell to 5% or below in the last year: Deep Track Capital, LP (3.8%, 2026-05-15), New Enterprise Associates 17, L.P. (4.9%, 2026-04-01), GREAT POINT PARTNERS LLC (3.5%, 2026-02-17), EVENTIDE ASSET MANAGEMENT, LLC (4.6%, 2026-02-13)
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2022.
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| NEA Management Company, LLC 1.62% of their portfolio | 5.6m $31.6m | Added +4.3m |
| Yiheng Capital Management, L.P. 1.07% of their portfolio | 2.6m $15.0m | Added +982.7k |
| BVF INC/IL 0.19% of their portfolio | 686.0k $4.0m | Unchanged |
| Commodore Capital LP 0.21% of their portfolio | 175.5k $995.0k | Reduced -87.2k |
| Ikarian Capital, LLC 0.04% of their portfolio | 15.6k $93.0k | Unchanged |
| CITIGROUP INC 0.00% of their portfolio | 12.0k $70.0k | Unchanged |
| CREDIT SUISSE AG/ 0.00% of their portfolio | 3.5k $20.0k | New |
| UBS Group AG 0.00% of their portfolio | 2.3k $13.0k | Added +1.0k |
| MORGAN STANLEY 0.00% of their portfolio | 1.2k $7.0k | Added +800 |
| CWM, LLC 0.00% of their portfolio | 100 $1.0k | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |